These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 9357529)
1. Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide. Seltzman HH; Fleming DN; Thomas BF; Gilliam AF; McCallion DS; Pertwee RG; Compton DR; Martin BR J Med Chem; 1997 Oct; 40(22):3626-34. PubMed ID: 9357529 [TBL] [Abstract][Full Text] [Related]
2. Potent anandamide analogs: the effect of changing the length and branching of the end pentyl chain. Ryan WJ; Banner WK; Wiley JL; Martin BR; Razdan RK J Med Chem; 1997 Oct; 40(22):3617-25. PubMed ID: 9357528 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. Adams IB; Ryan W; Singer M; Thomas BF; Compton DR; Razdan RK; Martin BR J Pharmacol Exp Ther; 1995 Jun; 273(3):1172-81. PubMed ID: 7791088 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological and behavioral evaluation of alkylated anandamide analogs. Adams IB; Ryan W; Singer M; Razdan RK; Compton DR; Martin BR Life Sci; 1995; 56(23-24):2041-8. PubMed ID: 7776830 [TBL] [Abstract][Full Text] [Related]
5. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability. Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Ross RA; Gibson TM; Brockie HC; Leslie M; Pashmi G; Craib SJ; Di Marzo V; Pertwee RG Br J Pharmacol; 2001 Feb; 132(3):631-40. PubMed ID: 11159715 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of cannabimimetic effects of structural analogs of anandamide in rats. Wiley JL; Ryan WJ; Razdan RK; Martin BR Eur J Pharmacol; 1998 Aug; 355(2-3):113-8. PubMed ID: 9760024 [TBL] [Abstract][Full Text] [Related]
8. Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor. Hampson AJ; Hill WA; Zan-Phillips M; Makriyannis A; Leung E; Eglen RM; Bornheim LM Biochim Biophys Acta; 1995 Nov; 1259(2):173-9. PubMed ID: 7488638 [TBL] [Abstract][Full Text] [Related]
9. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Felder CC; Briley EM; Axelrod J; Simpson JT; Mackie K; Devane WA Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7656-60. PubMed ID: 8395053 [TBL] [Abstract][Full Text] [Related]
10. Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas. Ng EW; Aung MM; Abood ME; Martin BR; Razdan RK J Med Chem; 1999 Jun; 42(11):1975-81. PubMed ID: 10354405 [TBL] [Abstract][Full Text] [Related]
11. Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides. Barg J; Fride E; Hanus L; Levy R; Matus-Leibovitch N; Heldman E; Bayewitch M; Mechoulam R; Vogel Z Eur J Pharmacol; 1995 Dec; 287(2):145-52. PubMed ID: 8749028 [TBL] [Abstract][Full Text] [Related]
12. Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand. Khanolkar AD; Abadji V; Lin S; Hill WA; Taha G; Abouzid K; Meng Z; Fan P; Makriyannis A J Med Chem; 1996 Oct; 39(22):4515-9. PubMed ID: 8893848 [TBL] [Abstract][Full Text] [Related]
13. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. Adams IB; Compton DR; Martin BR J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885 [TBL] [Abstract][Full Text] [Related]
14. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Devane WA; Hanus L; Breuer A; Pertwee RG; Stevenson LA; Griffin G; Gibson D; Mandelbaum A; Etinger A; Mechoulam R Science; 1992 Dec; 258(5090):1946-9. PubMed ID: 1470919 [TBL] [Abstract][Full Text] [Related]
15. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide. Cano C; Páez JA; Goya P; Serrano A; Pavón J; Rodríguez de Fonseca F; Suardíaz M; Martín MI Eur J Med Chem; 2009 Dec; 44(12):4889-95. PubMed ID: 19762126 [TBL] [Abstract][Full Text] [Related]
17. Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. Pertwee RG; Fernando SR; Griffin G; Abadji V; Makriyannis A Eur J Pharmacol; 1995 Jan; 272(1):73-8. PubMed ID: 7713152 [TBL] [Abstract][Full Text] [Related]
18. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. Smith PB; Compton DR; Welch SP; Razdan RK; Mechoulam R; Martin BR J Pharmacol Exp Ther; 1994 Jul; 270(1):219-27. PubMed ID: 8035318 [TBL] [Abstract][Full Text] [Related]
19. Cannabinoid properties of methylfluorophosphonate analogs. Martin BR; Beletskaya I; Patrick G; Jefferson R; Winckler R; Deutsch DG; Di Marzo V; Dasse O; Mahadevan A; Razdan RK J Pharmacol Exp Ther; 2000 Sep; 294(3):1209-18. PubMed ID: 10945879 [TBL] [Abstract][Full Text] [Related]
20. Biochemistry of the endogenous ligands of cannabinoid receptors. Di Marzo V; Deutsch DG Neurobiol Dis; 1998 Dec; 5(6 Pt B):386-404. PubMed ID: 9974173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]